Evaluation of in-vivo anti-implantation and in-vitro anti-proliferative activities of substituted 3-phenyl-4-phenylvinyl benzopyranone derivatives

Letters in Drug Design and Discovery

Volumn 6, Issue 1, 2009, Pages 46-50

  Gupta, Atul ^a,b   Sharmac, Ramesh ^a   Balapurec, Anil Kumar ^a   Keshrib, Govind ^a   Singhb, M M ^a   Raya, Suprabhat ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

Author keywords

Anti implantation agents; Antiproliferative agents; Drug research; Estrogen agonists; Estrogen antagonists; Estrogen receptors; Fertility regulation

Indexed keywords

ANTIESTROGEN; ANTIMITOTIC AGENT; BENZOPYRAN DERIVATIVE; CENTCHROMAN; TAMOXIFEN;

ANIMAL EXPERIMENT; ARTICLE; BIRTH CONTROL; BREAST ADENOCARCINOMA; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; MITOSIS INHIBITION; NIDATION; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

EID: 61849157510     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018009787158508     Document Type: Article

References (22)

1. Jordan, V.C.; O'Malley, B.W. Selective estrogen receptor modulators and antihormonal resistance in breast cancer. J. Clin. Onc., 2007, 25(36), 5815.
2. Dodge, J.A.; Richardson, T.I. Novel selective estrogen receptor modulators (SERMs). Ann. Rep. Med. Chem., 2007, 42, 147.
3. Neven, P. SERMs in breast cancer: current use and future challenges. Rep. Onc., 2007, 45.
4. Veeneman, G.H. Non-steroidal subtype selective estrogens. Curr. Med. Chem., 2005, 12, 1077.
5. Brzozowski, A.M.; Pike, A.C.W.; Dauter, Z.; Hubbard, R.E.; Bonn, T.; Engstrom, O.; Ohman, L.; Greene, G.L.; Gustafsson, J.-A.; Carlquist, M. Molecular basis of agonism and antagonism in the estrogen receptor. Nature, 1997, 389(6652), 753.
6. Marin, F.; Barbancho, M.C. Action of selective estrogen receptor modulators (SERMs) through the classical mechanism of estrogen action. Selective Estrogen Recept. Modulat., 2006, 71.
7. Ray, S.; Rastogi, R.; Kumar, A. Current status of estrogen receptors. Prog. Drug Res., 2002, 59, 201.
8. Dutertre, M.; Smith, C.L. Molecular mechanisms of selective estrogen receptor modulators (SERMs) action. J. Pharmacol. Exp. Ther., 2000, 295, 431.
9. Mueller, S.O.; Hall, J.M.; Swope, D.L.; Pedersen, L.C.; Korach, K.S. Molecular determinants of the stereoselectivity of agonist activity of estrogen receptors (ER) α and β. J. Biol. Chem., 2003, 278(14), 12255.
10. Ray, S.; Diwedy, I. Development of estrogen antagonists as pharmaceutical agents. Adv. Drug Res., 1997, 29, 172.
11. Lednicer, D. The chemical control of fertility. Marcel Dekker Inc. New-Yark 1969.
12. Goldzieher, J.W. The history of steroidal contraceptive development: the estrogens. Per. Biol. Med., 1993, 36(3), 363.
13. Perone, N. The history of steroidal contraceptive development: the progestins. Per. Biol. Med., 1993, 36(3), 347.
14. Plotz, E.J. Side effects of contraceptive steroids. I. Geburtshilfe und Frauenheilkunde, 1970, 30(3), 193.
15. Vojta, M. Side effects of contraceptive steroids. Ceskoslovenska Gynekologie, 1971, 36(5), 273.
16. Anand, N.; Ray, S. Centchroman-a post-coital contraceptive agent. Ind. J. Exp. Biol., 1977, 15(12), 1142.
17. Singh, M.M. Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders. Med. Res. Rev., 2001, 21(4), 302.
18. Gupta, A.; Raghunandan, R.; Kumar, A.; Maulik, P.R.; Dwivedy, A.; Keshri, G.; Singh, M.M.; Ray, S. Synthesis of 3-phenyl-4-phenylvinylbenzopyranones and the corresponding 2,2-dimethylbenzopyrans with structural similarity to estradiol, as estrogen receptor ligands. Med. Chem., 2007, 3(5), 446.
19. Ghosh, R.; Kamboj, V.P.; Singh, M.M. Interaction with anti-implantation and estrogen antagonistic activities of dlormeloxifene, a selective estrogen receptor modulator, by tetracycline in female Sprague-Dawley rats. Contraception, 2001, 64, 261.
20. Srivastava, S.; Sharma, R.; Balapure, A.K. Morphological and biochemical basis of centchroman as a novel antineoplastic agent in MCF-7 human breast cancer cells. Ind. J. Pharmac., 2004, 36(4), 238.
21. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J.T.; Bokesch, H.; Kenney, S.; Boyd, M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Nat. Can. Inst., 1990, 82(13), 1107.
22. Ray, S.; Singh, M.M.; Agarwal, A.K.; Kamboj, V.P. Enhanced antifertility activity of non-steroidal molecules with 3-n-butylamino-2-hydroxypropyloxy side chain. Contraception, 1987, 35(3), 283.